Nuvation Bio

Employee size

51-200

Organization type

Public Company

Headquarters

New York, NY

Founded

2018

Founded in 2018 by biopharma veteran David Hung, M.D., Nuvation Bio develops and commercializes oncology medicines for difficult-to-treat cancers. The company’s portfolio includes the FDA-approved therapy IBTROZI® (taletrectinib) and investigational treatments supported by global clinical programs, with offices in the United States and China.

• OnCusp Therapeutics, IncFounded in 2021 by Bing Yuan, Eric Slosberg, and Andy Fu, OnCusp Therapeutics is a Princeton-based clinical-stage biotech built around its founders’ global oncology development and partnering experience. The company advances promising preclinical research toward clinically validated cancer treatments, with its lead program CUSP06 now in clinical development for patients with advanced solid tumors.NEW YORK, NY
• Duo OncologyFounded by nanoparticle and drug-delivery researchers, Pittsburgh-based Duo Oncology is a clinical-stage biotechnology company developing tumor-activated medicines for cancer treatment. Its lead program, DUO-207, is designed to simplify chemotherapy by concentrating drug activity in tumors while reducing exposure in healthy tissue.PITTSBURGH, PA
• IG
  Indivumed GmbHFounded in 2002 by surgical oncologist Prof. Dr. Hartmut Juhl, Hamburg-based Indivumed GmbH is a biotech company developing precision-oncology therapeutics from patient-derived cancer data. Its clinically grounded R&D combines more than 20 years of standardized tumor-sample collection with proprietary multi-omics analysis and patient-derived tumor models to identify and validate drug targets. A global clinical network spanning North America, Europe, and Asia gives the company a broad, patient-native view of cancer biology.FREDERICK, MD
• NovocureNovocure grew from Professor Yoram Palti’s basement laboratory in Haifa, where he began exploring electric fields as a way to target cancer cells in 2000. Today, the international oncology company develops and commercializes Tumor Treating Fields therapy for patients facing some of the most aggressive solid tumors, while continuing research into wider applications.WAYNE, PA